Abstract
Testicular cancer is rare but is the most common cancer in males between 15 and 34 years of age. Two principal types of testicular cancer are distinguished: seminomas and non-seminomas. If detected early, the overall cure rate for testicular cancer exceeds 90%. In this study, artificial neural network (ANN) analysis as a prognostic tool was demonstrated regard to five year recurrence after the non-seminoma treatment. Data from 202 patients treated for non-seminoma were available for evaluation and comparison. A total of 32 variables were analysed using the ANN. The ANN approach, as an advanced multivariate data processing method, was demonstrated to provide objective prognostic data. Some of these prognostic factors are consistent or even imperceptible with previously evaluated by other statistical methods.
Author supplied keywords
Cite
CITATION STYLE
Marszałł, M. P., Krysiński, J., Sroka, W. D., Nyczak, Z., Stefanowicz, M., Waśniewski, T., … Buciński, A. (2012). ANN as a prognostic tool after treatment of non-seminoma testicular cancer. Central European Journal of Medicine, 7(5), 672–679. https://doi.org/10.2478/s11536-012-0027-7
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.